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Summary.-Using the data described in Paper I, we compare the effects ofthe same
treatment timings and doses given at different ages. Initiation with DMBA at 68 weeks
of age, followed 3 weeks later by TPA, has a significantly (P <0.0001) less rapid effect
on subsequent tumour incidence than does initiation at 8 or at 48 weeks of age,
followed 3 weeks later by TPA. We suggest that this is chiefly due not to changes in the
numbers of cells initiated by DMBA, but rather to a decrease in the promotional
efficacy of TPA in ageing mice.
MAN-r qualitatively different processes
have been found to affect cancer induction,
and the most promising framework for an
eventual synthesis of these several dif-
ferent mechanisms into a coherent descrip-
tion of the natural history of cancer is,
especially for epithelial tumours, some
kind of multi-stage model. One simplifying
assumption commonly made when for-
mulating multi-stage models (e.g. Armitage
& Doll, 1961; Peto, 1977; Whittemore &
Keller, 1.978) is that age per se has little
or no intrinsic relevance to the processes
of cancer induiction.§ This assumption
predicts that, for a particular carcinogenic
treatment which strongly affects, inter
alia, the first stage of cancer induction,
the cancer risk within a fixed time after
that treatment began should not, in
general, depend strongly on how old the
animal was when the treatment began
(excluding the peculiarly vulnerable foetal
and neonatal periods). This is an easy
prediction to test experimentally but,
despite this, there is surprisingly little
published evidence available about the
effects of age on the carcinogenicity of
treatments which include some initiation.
The most direct experimental evidence
(and a review of other experimental and
epidemiological evidence) is perhaps that
given by Peto et al. (1975), who found that
when mice were given 20 Hg ofbenzpyrene
twice weekly, starting at ages 10, 25, 40
or 55 weeks of age and continuing in-
definitely thereafter, the resultant cancer
risk was independent of age. The risk
depended strongly on how long the treat-
ment had been given, ofcourse, but among
animals of different ages which had all
been treated for the same length of time
the cancer incidence rate did not depend
on age.
This experiment yielded exactly the
result predicted by the simplest multi-
stage model theory; the cumulative result
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§ If, for example, a cell must undlergo 4 age-independent changes before becoming neoplastic, then the
probability of all 4 happeniing before age 60 might be 2 x 2 x 2 x 2 = 16 times greater than the probability of
all 4 happening before age :30, so the in(lependlence of age of the separate components of the wh}ole process of
caniier indluction (loes provwi(de a inatural explanatioin for the well knowvn inierease of cancer risks wvith
iiierleasing dturation of accumulation of (lamage.
26F. STENBACK, R. PETO AND P. SHUBIK
of the sequence of processes which are
presumably involved in cancer induction
seemed to be unaffected by the age of the
animals. However, if the first stage was
easier to induce in older animals and some
later stage was more difficult to induce,
these two effects could, in principle,
approximately cancel out, leaving the
final cancer incidence rate largely inde-
pendent of age (among animals treated
for the same duration), as observed. The
present study examines the dependence
on age at initiation in a system which,
unlike that studied by Peto et al. (1975)
does involve specific promotional stimuli
(due either to wound healing or to use of a
promoting agent) and some quite marked
dependences now emerge. If the ease with
which promotion can operate does vary
markedly with age, all attempts to make a
"multi-stage" synthesis of what is known
about initiation and promotion will be
seriously incomplete unless this age de-
pendence is allowed for.
METHODS
Among the 9 treatment groups of the
initiation/promotion experiment described in
the accompanying paper (Stenback et al.,
1981) there are some groups which have the
same interval between initiation and the start
of promotion, and which differ only in the
age of the animals during treatment. These
groups, and the analyses which we shall per-
form on them, are listed in the Table. We can
assess separately the dependence on age at
treatment of the effects of (a) initiation fol-
lowed by immediate promotion, (b) initiation
followed by delayed promotion, and (c)
initiation without promotion.
In each case, we may assess the response
either in terms of (i) the total number of
tumours arising within a particular 20-week
period of time (to which one mouse may
contribute more than one tumour, which
makes the calculation of reliable P values
difficult), or in terms of (ii-iv) the number of
tumour-bearing animals, i.e. by a standard
time-to-first-tumour analysis, with P values,
of (ii) all tumours, of any size or type, or
(iii) 1Omm tumours, or(iv)malignanttumours.
Details of the experimental and statistical
TABLE.-Times of initiation and promotion
in various subgroups of aninmals. Each
group was replicated with 10, 30, 100
or 300 jig of DMBA as the initiating
dose.
Weeks
between
Age Ages initiation
(weeks at dutlrinlg ain(d
Group initiation) promotion promotion
Initiationi followed by immnedliate promotion
a 8 11 26 :3
f 48 51-66 :3
1b 68 71-86 3
Analysis: from Wteek 4 from initiation.
Initiatioin followed by delayed promotion, igolornig
tulmoturs which arise before promotion
e 8 31-46 2:3
g 48 71-86 23
Analysis: from Week 24 from iniitiation.
23 unpromote(l weeks after initiatioin (except for thie
high-(lose animals, who uinderwveint promotion by
wouin(l liealing as oleers an(d erIosions eause( b
the initiator recovered)
I r 8 r31-
(I 8 J51-
e 8 71-
i Is 8 never
g 48 71--
2:3
43
63
23
Analysis: (hiiriiig WVeeks 4-23 firoin iiiitiation only
with the braeketed groups, pooleil andl treated as
one group.
methods are given in the previous paper by
Stenhack et al. (1981).
RESULTS
The dependence on age of the effects of
initiation followed by imimediate promotion
Initiation at age 8 weeks followed by
immediate promotion, and initiation at
48 weeks followed by immediate promo-
tion, had similar effects on the total
numbers of tumour-bearing animals (Fig.
1: for numerical details, see Appendix
Tables a and b). But, for every index of
response, initiation at 68 weeks followed
by immediate promotion had much less
effect. The relative diminution of effect
was greater when assessed in terms of
large or of malignant tumours than when
assessed in terms of papillomas, but even
for time to first tumour the shortfall was
highly significant (P < 00001). This dimi-
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FIG. 1. -Tumour response: O/E values com-
paring Groups a, f, an(d h, initiated at 8, 48
and 68 weeks and promoted 3-18 weeks
later (from Appendlix Tables a and b).
0 All tumours witlin 20 weeks. 0 First
tutmours of any size or type (witlh approxi-
mate 95% confidence intervals). [ First
10mm tumours. A First malignant tumour.
nution of effect is confirmed by the life-
table analysis provided by van Duuren
et al. (1978) in which it was shown that
initiation at Week 6 of age followed by
promotion from Week 8 onwards produced
papillomas more rapidly than initiation
at Week 56 followed by promotion from
Week 58 onwards.
Our data indicate that at between 50
and 80 weeks of age there is a substantial
decrease either in the response to DMBA
or in the response to TPA (which was
applied to Group h from Weeks 71 to
86), and shows that multistage models
must be formulated with great care in the
particular context of initiation and pro-
motion.
The dependence on age of the effects of
initiation followed by delayed promotion
For all 4 indices of response there was
a slightly but non-significantly lower res-
ponse to promotion among animals initia-
ted at Week 48 and promoted at Weeks
71-86 than in animals treated 40 weeks
earlier (Fig. 2: for numerical details, see
Appendix Tables c and d). The decrease
does not seem as marked as in Fig. 1,
where initiation at Week 68 and promotion
.
,
a t tL* (wd :
FIG. 2. Tumour response: O/E values com-
paring the responses to dlelaye(d promotion
in Groups c and g, initiated at 8 and 48
weeks, respectively and promoted 23-38
weeks later (from Appendix Tables e and
d). Symbols as in Fig. 1.
at Weeks 71-86 were studied, even though
the age at promotion was the same.
The dependence on age of the short-term
effects of initiation without immiediate
promotion
Surprisingly, for DMBA given alone
with no immediate promotion, there
appears to be clear evidence of an in-
creased short-term yield of tumours if
initiation is at 48 rather than 8 weeks of
age, tumours being observed during the
subsequent 23 weeks without promotion
(Fig. 3: for numerical details, see Appen-
dix Tables e and f). This is odd, since
it concerns an agent rather similar to that
studied by Peto et al. (1975) with which no
age-related changes in effect were evident
(and see also the footnote to Appendix
Table e), but it is too highly significant a
finding to be dismissed easily as the result
of chance. It is argued in Stenback et al.
(1981) that if the effect is real, the most
plausible explanation is that the healing
of ulcers, erosions and related changes is
slower in old mice than in young ones, and
that the promotional stimulus associated
with such healing is therefore more pro-
e7 4-7o---i .,:~
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FIG. 3.-Tumour response: ot
pecte( numbers. O/E values fo
for the response to initiati(
Groups c and g, initiate(l at 8 a
andl observe(lduring the next
(from Appendix Tables e and
as in Fig. 1.
longed and so more potent.
explanation for this increase
of DMBA alone, it indica
order to produce the rather
creases in the effects of iir
promotion that was seen in
must be an even stronge
decrease in promotional eff
than was suggested by Fig.
(It may be noteworthy t
number of tumours arisin
weeks without applied pronr
weeks containing a perioc
promoter is about the same
at 8 as for initiation at 48 we
that at 48 weeks we get n
without promotion and then
promotion. This is, however,
cidental rather than signific,
Pereira et al. (1979) have measured
directly the amount of benzpyrene which
actually binds to mouse epidermal DNA,
and have found simple proportionality
between the amount applied and the
amount subsequently bound to the DNA.
If the same can be done for DMBA then
:::: :; it will be possible, by studying animals of
:: different ages, to determine whether age daffects the proportion of an applied dose
of DMBA which eventually binds to the
-w.^ DNA. Likewise, certain biochemical ef-
-^+-:- fects of TPA applied to the skin of living
mice, such as ornithine decarboxylase
induction, are quantitatively measurable
(Verma et al., 1978), as are certain histo-
logical effects (Klein-Szanto et al., 1980)
; -~ : and it would therefore be possible to deter-
mine whether the age of a mouse affects
.: :; the biochemical or histological response
of its skin to TPA. Specific measurements
such as these may yield more direct
i :1 evidence than the present experiment does
)served- eX- as to whether it is initiation or promotion
r the groups which takes place less readily in older
)n alone of animals.
11(1 48 weeks
4-23 weeks There is a large literature on mathe-
f). Symbols matical formulations ofmulti-stage models
(for review and references, see Whittemore
& Keller, 1978), almost all of which im-
Whatever the plicity or explicitly assumes that some or
in the effects all of the transitions through which cells
Ltes that, in pass en route from normality to full trans-
r marked de- formation are largely independent of age.
iitiation with Our data show clearly that such assump-
Fig. 1, there tions are not valid for the special case of
r age-related initiation with a single potent dose of
Sects of TPA DMBA followed by promotion by wound
1 alone. healing or by TPA. This does not prove
hat the total that such assumptions are also seriouslv
g during 23 wrong under the conditions of chronic
zoter plus 20 exposure to much lower environmental
I of applied doses of various chemicals (or to spon-
for initiation taneous cellular accident) that are usually
eks. It is just more relevant to human carcinogenesis.
nore tumours However, it does suggest a need for more
fewer during caution in the mathematical formulation
perhaps coin- of multi-stage models than has commonly
ant.) been exercised. Our results do not cast
,, , ,,_ 4_, i,,; ...... , ". "-I !if-,
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any doubt on the fundamental assumption
ofmulti-stage model theory, that accumu-
lation of more than one heritable change
in a normal tissue cell is needed before
that cell can act as the progenitor of a
neoplastic clone. They do, however, indi-
cate that many of the quantitative for-
mulations of the consequences of this
fundamental assumption may have been
seriously over-simplified, at least where
they dealwith specificpromotional stimuli.
Initiation with toxic or near-toxic
doses of DMBA followed by strong pro-
motion is obviously a poor model for the
very slow accumulation of precancerous
changes in human tissues, and the aetio-
logy of papillomas may obviously be a
very poor model for that of infiltrating
carcinomas. However, the anomalies we
have discovered suggest that until the
nature of the various stages of human
carcinogenesis is understood and their
rates of occurrence under realistic condi-
tions of mild insult can be directly deter-
mined, the formulation of quantitative
models for multistage carcinogenesis
should be approached more cautiously
that hitherto.
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APPENDIX
TABLE a.-Thee effects of age on total tumour yield after immediate promotion
Total numbers of tumours (including second and subsequent tumours) during the 20 weeks from the start
of promotion, among animals initiated at different ages, promoted during Weeks 3-18 thereafter, and sur-
viving at least 23 weeks after initiation.
MS=Number of Mice Surviving at least 23 weeks after initiation.
0=Number of tumours Observed to arise on these survivors during Weeks 4-23.
E=Number of tumours Expected to do so ifthe number per survivor depends on dose level but not on age
at initiation.
T/M=Tumours per mouse-O/MS.
Protocol a
Age at initiation 8
Age during promotion 11-26
MS 0 E
300 ,ug initiation 73 146 117-9
2.0 T/M
100 ,ug initiation 34 49 33-1
1.4T/M
30 ,ug initiation 38 25 30-9
0-7 T/M
10 ug initiation 39 25 19-3
0-6 T/M
Total ofabove
(all doses) 184 245 201-2
Total 0 . total E* O/E = 1-22
f
48
51-66
MS 0 E
40 55 64-6
1-4 T/M
37 39 36-0
1.1 T/M
47 47 38-2
10 T/M
52 33 25-8
0-6T/M
176 174 164-6
O/E = 1.06
h
68
71-86
MS 0 E
30 30 48-5
1-0 T/M
38 18 36-9
0-5T/M
38 28 30-9
0-7 T/M
36 5 17-9
0-14T/M
142 81 134-2
O/E=0-60
Totals
(3 protocols)
MS 0 E
143 231 231-0
1-6 T/M
109 106 106-0
1-0 T/M
123 100 100-0
0-8 T/M
127 63 63-0
0-5T/M
502 500 500-0
O/E = 1-00
necessarily
* It is not valid to compare the average number of tumours per mouse in the total for all doses, because
the proportion ofhigh-dose animals in Protocol a is greater than in Protocol h. However, the ratios ofTotal 0
to Total E can be compared validly with each other, as here.
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TABLE b.-The effects of age on the number of tumour-bearing animals, after immediate
promotion
Incidence rates of (ii) first tumours irrespective of size or type, (iii) first 10 mm tumours, and (iv) first
malignant tumours, among animals initiated at various ages and promoted from Weeks 3-18 thereafter.
The expected numbers. E, and P values were calculated using methods of analysis appropriate for in vivo
tumours, using the times wben (ii) appearance, (iii) size > 10 mm and (iv) apparent malignancy were first
noted.
N=Number of animals alive at the end of Week 3 after initiation, excluding any which had already
developed the tumour type of interest.
0=Number of such animals which were Observed to develop the tumour type of interest at any time after
Week- 3.
E =Number of such animals Expected to do so if onset rates depend on dose level and on time since
initiation but not oI1 age at initiation. These Expecteds were calculated using the methods described for
tumours observed in a mortality-independent context in IARC (1980).
Tumotit
type of DMBA
interest dose
(ii) any 300 ttg
(ii) any 100 jug
(ii) any 30 ,ug
(ii) any l 0 ,ug
(ii) any
tumours all* (loses
Total 0÷
total E
(iii) 10MM
tumours all* doses
Total 0÷
total E
(iv) maligniatit
tumours all* (loses
Total 0
total E
Protocol a
Initiation at
age 8 weeks
Promotion at
1 -26 weeks
N O E
80 59 47-2
40 26 15-8
39 12 15-4
40 14 10-8
Protoclo f
Initiation at
age 48 weeks
Promotion at
51-66 weeks
N O E
58 32 33-6
58 32 26-5
59 26 16-0
56 23 14-9
Protocol i
A
Initiation at
age 68 weeks
Promotion at
71-86 weeks
N O E
78 32 42-2
72 17 32-7
77 12 18-6
70 5 16-3
199 I11 89-2 231 113 90 9 297 66 109-9
O/E= 1-24 O/E= 1-24
199 61 503 232 44 32-2
O/E=1 21 O/E= 1-37
199 40 34-9 232 26 20-6
O/E= 1-15 O/E= 1-26
O/E = 0 60
303 2 24-5
O/E = 0-08
303 3 13-5
O/E = 0-22
Totals (all 3
protocols) and
P values for
iiegative
trend, a-+f-+h
N O E
216 123 123-0
170 75 75-0
175 50 50.0
166 42 42-0
727 290 290-0
P < 0-0001
734 107 107-0
P<0-0001
734 69 69-0
P <0.05
* These total N, total 0 and total E values are derived by summation of the N, 0 and E values in 4
separate (lose-specific analyses.
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TABLE c.-The effects of age on total tumour yields after delayed prontotion
Total numbers of tumours (including second and subsequent tumours) during the 20 weeks from the start
of promotion, among animals initiated at the start of promotion, among animals initiated at different ages,
promoted during Weeks 23-38 thereafter, and surviving at least 43 weeks after initiation.
Protocol c Protocol g
Initiation at Initiation at
age 8 weeks age 48 weeks
=~~~~~~r
A
MS O E MS O E
300 tg initiation 34 27 27-2 11 9 8-8
0-8 T/M 0-8 T/M
100 ,uginitiation 25 11 14-0 25 17 14-0
0.4 T/M 0 7 T/M
30 ,ug initiation 32 18 14-6 36 13 16-4
0-6 T/M 0 4 T/M
10 ,ug initiation 35 28 17-7 36 8 18-3
0-8 T/M 0-2 T/M
Total of above
(all doses) 126 84 73-5
Total O total E* O/E = 1-14
108 47 57-5
O/E=0 82
* Footnote and abbreviations as in Table a.
Total of
c and g
MS 0 E
45 36 36-0
0-8 T/M
50 28 28-0
0-6 T/M
68 31 31-0
05 T/M
71 36 36-0
0 5T/M
234 131 131-0
O/E= 1 00
necessarily
TABLE d.-The effects of age at initiation on the numbers of tumour-bearing animals
after delayed promotion
Incidence rate among animals initiated at various ages, alive and free of the tumour type of interest 23
weeks after initiation, and promoted from Week 23 after initiation for 15 weeks (or less for animals dying
before Week 38). Notation as in Table b. The period of observation runs from Week 23 after initiation to
death or to the first occurrence of a tumour of the type that is of interest.
Tumour
type of
interest
(ii) any
(ii) any
(ii) any
(ii) any
DMBA
dose
300 ,ig
100 ug
30 jug
10 Mg
Protocol c
Initiation at
8 weeks
N O E
46 21 20-2
27 10 8-8
37 9 11-6
39 21 12-1
(ii) any
tumours all* doses 149 61 52-7
Total 0±
total E O/E = 1-16
(iii) 1Omm
tumours all* doses 178 25 23-1
Total 0 .
total E O/E = 1-08
(iv) malignant
tumours all* doses 182 19 18-0
Total 0÷
total E O/E = 1-06
Protocol g
Initiation at
48 weeks
N O E
24 7 7-8
50 10 11-2
58 15 12-4
67 9 17-9
179 41 49-3
O/E=0-83
232 12 13-9
O/E = 0-86
242 8 90
O/E = 0-89
Total (both
protocols) and
P values for
differences
between
c and g
A
N O E
70 28 28-0
77 20 20-0
95 24 24-0
106 30 300
348 102 102-0
P = 0-07
410 37 370
P=0.5
424 27 27-0
P=0 7
* Footnote and abbreviations as in Table b.
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TABLE e.-The effects of age at initiation on the total tumour yield without TPA promotion
Total numbers of tumours (including second and subsequent tumours) arising during Weeks 4-23 after
initiation amonganimals initiated at different agesand aliveandumpromoted forat least 23 weeks thereafter.
Protocols
c, d, e and i
Initiation at
age 8 weeks
MS 0 E
300 ,uginitiation 221 94 112-1
0.4 T/M
100 ,ug initiation 211 66 59-4
0-3 T/M
30 jtg initiation 210 0 4-6
0-00 T/M
10,uginitiation 214 0 1-5
0-00 T/M
Total ofabove
(all doses) 856 160 177-6
Total 0÷total Et O/E =0-90
Protocol g
Initiation at
age 48 weeks*
MS 0 E
55 46 27-9
0.8 T/M
59 10 16-6
0-2 T/M
63 6 1-4
0-10 T/M
72 2 0-5
0.03T/M
249 64 46-4
O/E = 1-38
Total of
c, d, e, i and g
MS 0 E
276 140 140-0
0-5T/M
270 76 76-0
0-3 T/M
273 6 6-0
0.02 T/M
286 2 2-0
0-01 T/M
1105 224 224-0
O/E = 1 00
necessarily
* Tumour yield at 48 weeks. As part of a more recent experiment on animals of the same sex and strain,
alboit from a different source, initiated similarly at 48 weeks with these same doses, the yields 23 weeks later
were 4/40, 4/37, 0/43 and 0/40 tumours/mouse, suggesting that the figure of 0-8 T/M in this table may not be
reproducible.
t Footnote and abbreviations as in Table a.
TABLE f.-The effects of age at initiation on the numbers of tumour-bearing animals,
without TPA promotion
Incidence rates of (ii) first tumours, irrespective of size or type, (iii) first 1Omm tumours, and (iv) first
malignant tumours, among animals initiated at various ages, alive 3 weeks later and left for more than
3 weeks without promotion. The period of observations runs from 3 weeks after initiation to the eventual
start of promotion, to death, or to the first onset of the tumour type of interest.
Protocols
c, d, e and i
I
Initiation at
8 weeks
N O E
340 102 117-3
260 57 55-2
260 0 3-8
260 0 0-7
Protocol g
Initiation at
48 weeks
N O E
80 38 22-7
80 15 16-8
80 5 1-2
80 1 0-3
Totals (both
protocols) and
P values for
differences
between
8 and 48
N O E
420 140 140-0
340 72 72-0
340 5 5-0
340 1 1-0
(ii) any
tumours all* doses 1120 159 177-1
Total 0÷
total E O/E =0-90
(iii) 10mm
tumours all* doses 1120 29 36-6
Total 0÷
totalE O/E=0-79
(iv) malignant
tumours all* doses 1120 6 10-9
Total 0÷
total E O/E =0-55
* Footnote and abbreviations as in Table b.
320 59 40-9 1440 218 218-0
O/E = 1-44 P<0-002
320 17 9-4 1440 46 46-0
O/E = 1-82 P<0-01
320 8 3-1 1440 14 14-0
O/E=2-57 P<0-02
Tumour
type of
interest
(ii) any
(ii) any
(ii) any
(ii) any
DMBA
dose
300 ug
100 jig
30 ,ig
10 ,ug
23